Cyclic peptides lead to New Biologics, such as highly multi-specific IgG or “Small but multi specific dAb”.
| No. | Construct | Stage |
| No.1 | anti-CTLA-4 pep/anti-PD-1 dAb | Lead optimization |
| No.2 | anti-Her2 pep/anti-Her2 dAb | Under construction |
| No.3 | anti-IL-6 pep/anti-TNF-α dAb | Under construction |
| No.4 | anti-Erk2 pep/GFP | Available for R&D (Imaging tool) |
(dAb: domain antibody)
Related Products and Services
PUREfrex® RD
Drug Discovery